drugset / Trial / NCT07388667

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667

Phase 1 Active not recruiting 120 enrolled Merck Sharp & Dohme LLC
RandomizedSequentialTriple-blindBasic science

Summary

Researchers are looking for new weight loss medicines for people with higher body weight. The study medicine, MK-4082, is different from similar weight loss medicines because people take it as a pill instead of an injection. Before giving a study medicine to people with a health condition, researchers first do studies to find a safe dose level (amount) of the study medicine that can be used in future studies. The goals of this study are to learn about: * The safety of MK-4082 and if people tolerate it * What happens to different MK-4082 dose levels in a person's body over time

Timeline

Start
2026-03-04
Primary completion
2026-09-02
Completion
2026-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-4082 Unknown Oral

Indications

No indication recorded.